Tuesday , April 24 2018

Recent Posts

FDA Grants Breakthrough Therapy Designation to Pfizer’s Trumenba for Prevention of Invasive Meningococcal B Disease

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that TRUMENBA® (Meningococcal Group B Vaccine) received Breakthrough Therapy …

Read More »

FDA Approves Crysvita, The First Therapy for X-Linked Hypophosphatemia, A Rare Inherited Form of Rickets

NOVATO, Calif. and TOKYO and LONDON, April 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development …

Read More »